Ca(2+)/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Ca(2+) — decreases tumour necrosis factor alpha concentration
Evidence strength: very limited.Finding“After adjustment for potential confounders, individuals in the calcium (-3.1 ± 1.3, P < .05), vitamin D (-3.1 ± 1.3, P < .05), and joint calcium-vitamin D groups (-3.4 ± 1.3, P < .05) had greater reductions in serum TNF-α concentrations compared with placebo (0.1 ± 1.2).”
Quoted verbatim from Calcium-vitamin D cosupplementation influences circulating inflammatory biomarkers and adipocytokines in vitamin D-insufficient diabetics: a randomized controlled clinical trial.. - Study
- RCT
- Duration
- 8 weeks
- Dose
- 1000 mg/d calcium plus vitamin D placebo for 8 weeks
- Population
- Vitamin D-insufficient adults with type 2 diabetes; calcium-alone arm against a double-placebo arm; confounder-adjusted analysis
Calcium-vitamin D cosupplementation influences circulating inflammatory biomarkers and adipocytokines in vitamin D-insufficient diabetics: a randomized controlled clinical trial.2014PMID:2521555710.1210/jc.2014-1977Permalink
To cite this finding: https://catalystproject.ai/e/01M5SR949Q6NJWWD90PMGC08TC